Powerful presentations at the Lunch Symposium today at <a href="https://twitter.com/hashtag/STSCoronary2025.?src=hashtag_click" target="_blank">#STSCoronary2025.</a>

Leading surgeons, including Dr. Cox and Dr. Rushing, emphasized the importance of treating Afib in CABG patients – not just to manage symptoms, but to help restore normal sinus rhythm and improve long-term

With high recurrence rates, esophageal risks &amp; more, EP Dr. Zayad Eldadah walks through the challenges of an endo-only approach to LSPAF treatment.​

Discover how the Hybrid Convergent procedure could be the right treatment option for your LSPAF patients: <a href="https://t.co/JRYQOdzU1f&quot; target="_blank">https://t.co/JRYQOdzU1f</a&gt;

Welcome to the 8th Hybrid AF™ Therapies Summit in London, UK! This event is a chance for cardiothoracic surgeons and electrophysiologists to share skills, best practices, and improve complex AF outcomes. ​

Learn more about Hybrid Therapies and their role in advancing patient care: <a href="https://lnkd.in/eFVHFrbj&quot; target="_blank">https://lnkd.in/eFVHFrbj</a&gt;​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=afibmanagement&highligh…; target='_blank'>#afibmanagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>

After discharge, patients are left with fewer pain management options. Addressing and providing patients with the right pain management approach can make all the difference during recovery. ​

Discover more about the impact of transitional pain at: <a href="https://t.co/qDhqUhYHeu&quot; target="_blank">https://t.co/qDhqUhYHeu</a&gt;

Our people make us a Top Workplace, and we’re thrilled to be recognized by <a href="https://twitter.com/StarTribune&quot; target="_blank">@StarTribune</a> as a 2025 Top Workplace for our Minneapolis office!

Empowered teams and passionate people lead to better patient care.

<a href="https://twitter.com/hashtag/ThisisAtriCure?src=hashtag_click&quot; target="_blank">#ThisisAtriCure</a> <a href="https://twitter.com/hashtag/Topworkplace?src=hashtag_click&quot; target="_blank">#Topworkplace</a>

Our people make us a Top Workplace, and we’re thrilled to be recognized by Star Tribune as a 2025 Top Workplace for our Minneapolis office!

Empowered teams and passionate people lead to better patient <a href="https://www.facebook.com/hashtag/care

ThisisAtriCure" target="_blank">care.

#ThisisAtriCure</a> <a href="https://www.facebook.com/hashtag/Topworkplace&quot; target="_blank">#Topworkplace</a>

We’re just one day away from the Hybrid AF™ Therapies Summit in London. We look forward to welcoming participants for a full day of scientific exchange focused on hybrid approaches to treating persistent and long-standing persistent AF. ​

Learn more about Hybrid Therapies: <a href="https://lnkd.in/eFVHFrbj&quot; target="_blank">https://lnkd.in/eFVHFrbj</a&gt;​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=afibmanagement&highligh…; target='_blank'>#afibmanagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>

Medications and conventional ablation techniques have been used to treat IST symptoms, but neither option is fully effective. That's why hybrid ablation is being studied for safety and effectiveness in the HEAL-IST Trial. ​​​
​​​
Learn more about the HEAL-IST Trial at:

Do you have inappropriate sinus tachycardia (IST)? If you've become resistant or intolerant to your medications, you may be a candidate for the HEAL-IST Trial. ​​
​
For participation criteria and study details, visit HEAL-IST.com

Join us at JFEF 2025 by SFCTCV - Société Savante on Wednesday, 18 June from 14:10 to 15:40 in the Auditorium for the AtriCure sponsored session: "Mitral Valve: What’s New in 2025?". Moderated by Dr. Marc Ruel and Prof. Frédéric Collart, the session will explore key topics including the role of AF guidelines in surgical planning, LAA Management. ​

View the full JFEF 2025 program here: <a href="https://lnkd.in/e4J4-Qj7&quot; target="_blank">https://lnkd.in/e4J4-Qj7</a&gt;​

Rejoignez la session sponsorisée par AtriCure durant les JFEF de la SFCTCV 2025 le mercredi 18 juin de 14h10 à 15h40 dans l’Auditorium sur : « La valve mitrale : quoi de neuf en 2025 ?».Modérée par le Dr. Marc Ruel et le Prof. Frédéric Collart, cette session abordera des thèmes clés tels que le rôle des recommandations sur la fibrillation atriale dans la planification chirurgicale, la gestion de l’auricule gauche, ainsi que l’utilisation de techniques avancées comme la décalcification ultrasonique dans les cas complexes de pathologie mitrale.

Consultez le programme complet des JFEF 2025 ici: <a href="https://lnkd.in/e4J4-Qj7&quot; target="_blank">https://lnkd.in/e4J4-Qj7</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=jfef2025&highlightedUpd…; target='_blank'>#jfef2025</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAM&highlightedUpdateU…; target='_blank'>#LAAM</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=afib&highlightedUpdateU…; target='_blank'>#afib</a>